Image Guided Therapy System Market

Executive Summary

Image Guided Therapy System Market was valued at US $5.44 billion in 2021 and is projected to grow at 6.69% CAGR over the forecast period to reach US $8.03 billion by 2027. Image Guided Therapy System Market represented US $0.66 billion opportunity over 2019-2021 and estimated to create US $2.59 billion opportunity in 2027 over 2021.

Image Guided Therapy System from Consainsights analyses the Image Guided Therapy System Market in the Life Sciences industry over the forecast period to 2027.

Image Guided Therapy System research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Image Guided Therapy System segmentation includes Product Type, Application, End-user and Geography.

Based on the Product Type, the Image Guided Therapy System analysis covers Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI), Endoscopes, Positron Emission Tomography (PET), Others.

In Product Type segment, Ultrasound Systems segment has highest cagr growth of 5.93%.

Based on the Application, the Image Guided Therapy System analysis covers Neurosurgery, Cardiac Surgery, Urology, Orthopedic Surgery, Others.

In Application segment, Neurosurgery segment has highest cagr growth of 5.93%.

Based on the End-user, the Image Guided Therapy System analysis covers Hospitals, Ambulatory Surgery Centers, Clinics.

In End-user segment, Hospitals segment has highest cagr growth of 5.93%.

Based on the region, the Image Guided Therapy System analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare, Analogic Corporation, Brainlab, Medtronic Plc, Varian Medical Systems, Inc, KARL STORZ SE & Co. KG, Stryker Corporation and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product Type

Introduction

In 2021, Ultrasound Systems segment has the highest revenue of US $2.09 billion and is expected to grow at CAGR of 5.93% by 2027 Ultrasound Systems segment has highest cagr growth of 5.93%.

Ultrasound Systems

Ultrasound Systems segment was valued at US $1.84 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $3.09 billion by 2027. Ultrasound Systems segment represented US $0.25 billion opportunity over 2019-2021 and estimated to create US $0.99 billion opportunity in 2027 over 2021.

Computed Tomography (CT) Scanners

Computed Tomography (CT) Scanners segment was valued at US $1.30 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $2.18 billion by 2027. Computed Tomography (CT) Scanners segment represented US $0.18 billion opportunity over 2019-2021 and estimated to create US $0.70 billion opportunity in 2027 over 2021.

Magnetic Resonance Imaging (MRI)

Magnetic Resonance Imaging (MRI) segment was valued at US $0.72 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $1.21 billion by 2027. Magnetic Resonance Imaging (MRI) segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.39 billion opportunity in 2027 over 2021.

Endoscopes

Endoscopes segment was valued at US $0.54 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $0.91 billion by 2027. Endoscopes segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.29 billion opportunity in 2027 over 2021.

Positron Emission Tomography (PET)

Positron Emission Tomography (PET) segment was valued at US $0.29 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $0.48 billion by 2027. Positron Emission Tomography (PET) segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.16 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $0.09 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $0.16 billion by 2027. Others segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.05 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Neurosurgery segment has the highest revenue of US $2.23 billion and is expected to grow at CAGR of 5.93% by 2027 Neurosurgery segment has highest cagr growth of 5.93%.

Neurosurgery

Neurosurgery segment was valued at US $1.96 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $3.29 billion by 2027. Neurosurgery segment represented US $0.27 billion opportunity over 2019-2021 and estimated to create US $1.06 billion opportunity in 2027 over 2021.

Cardiac Surgery

Cardiac Surgery segment was valued at US $1.15 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $1.93 billion by 2027. Cardiac Surgery segment represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.62 billion opportunity in 2027 over 2021.

Urology

Urology segment was valued at US $0.70 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $1.17 billion by 2027. Urology segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.38 billion opportunity in 2027 over 2021.

Orthopedic Surgery

Orthopedic Surgery segment was valued at US $0.71 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $1.19 billion by 2027. Orthopedic Surgery segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.38 billion opportunity in 2027 over 2021.

Others

Others segment was valued at US $0.26 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $0.44 billion by 2027. Others segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.14 billion opportunity in 2027 over 2021.

End-user

Introduction

In 2021, Hospitals segment has the highest revenue of US $2.47 billion and is expected to grow at CAGR of 5.93% by 2027 Hospitals segment has highest cagr growth of 5.93%.

Hospitals

Hospitals segment was valued at US $2.17 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $3.64 billion by 2027. Hospitals segment represented US $0.30 billion opportunity over 2019-2021 and estimated to create US $1.17 billion opportunity in 2027 over 2021.

Ambulatory Surgery Centers

Ambulatory Surgery Centers segment was valued at US $1.48 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $2.48 billion by 2027. Ambulatory Surgery Centers segment represented US $0.20 billion opportunity over 2019-2021 and estimated to create US $0.80 billion opportunity in 2027 over 2021.

Clinics

Clinics segment was valued at US $1.13 billion in 2019 and is projected to grow at 5.93% CAGR over the forecast period to reach US $1.90 billion by 2027. Clinics segment represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.61 billion opportunity in 2027 over 2021.